RGC
Regencell Bioscience Holdings Limited
Price Chart
Latest Quote
$12.01
-2.81 (-18.96%)
Current Price
| Previous Close | $14.82 |
| Open | $14.55 |
| Day High | $14.85 |
| Day Low | $11.89 |
| Volume | 377,357 |
Stock Information
| Shares Outstanding | 494.49M |
| Total Debt | $386K |
| Cash Equivalents | $2.36M |
| Net Income | $-7.05M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Market Cap | $5.94B |
| EPS (TTM) | $-0.01 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $5.94B |
| Income | $-7.05M |
| Book/sh | $0.00 |
| Cash/sh | $0.00 |
| Employees | 10 |
Financial Ratios
| Quick Ratio | 1.42 |
| Current Ratio | 1.42 |
| Debt/Eq | 31.68 |
Returns & Margins
| ROA | -84.97% |
| ROE | -177.66% |
Ownership
| Insider Ownership | 88.38% |
| Institutional Ownership | 0.13% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| P/B | 6005.00 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $21.17 |
| SMA50 | $25.61 |
| SMA200 | $22.45 |
| RSI | 14.42 |
| ATR | 2.1763 |
| Shares Float | 56.28M |
| Short Float | 1.41% |
| Short Ratio | 7.76 |
| Volatility | 1.64 |
| Rel Volume | 3.12 |
Performance History
| Week | -39.00% |
| Month | -55.52% |
| Quarter | -55.53% |
| 6 Months | -28.08% |
| YTD | -41.53% |
| Year | -84.60% |
| 3 Years | +1740.24% |
| 10 Years | +4246.47% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-18 | $12.01 | 380,700 |
| 2026-06-17 | $14.82 | 198,300 |
| 2026-06-16 | $16.73 | 157,400 |
| 2026-06-15 | $17.09 | 153,400 |
| 2026-06-12 | $18.83 | 85,100 |
| 2026-06-11 | $19.69 | 92,500 |
| 2026-06-10 | $20.45 | 52,400 |
| 2026-06-09 | $20.31 | 94,100 |
| 2026-06-08 | $21.39 | 123,500 |
| 2026-06-05 | $19.99 | 101,800 |
| 2026-06-04 | $22.16 | 112,900 |
| 2026-06-03 | $23.75 | 95,500 |
| 2026-06-02 | $23.15 | 77,900 |
| 2026-06-01 | $24.17 | 73,300 |
| 2026-05-29 | $23.90 | 70,800 |
| 2026-05-28 | $24.11 | 66,000 |
| 2026-05-27 | $23.71 | 137,800 |
| 2026-05-26 | $24.31 | 178,100 |
| 2026-05-22 | $25.80 | 143,100 |
| 2026-05-21 | $27.00 | 43,800 |
| 2026-05-20 | $27.39 | 46,600 |
| 2026-05-19 | $27.00 | 97,600 |
About Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.
đ° Latest News
Auditor Change Puts Regencell Bioscience Governance And Cash Runway In Focus
Simply Wall St. âĸ 2026-04-27T10:07:26Z
Taiwan Semiconductor Upgraded, Eli Lilly Downgraded: Updated Rankings on Top Blue-Chip Stocks
InvestorPlace âĸ 2026-04-20T19:25:44Z
Here's Why I Wouldn't Touch Regencell Bioscience With a 10âFoot Pole Right Now
Motley Fool âĸ 2026-03-07T02:35:00Z
A Look At Regencell Bioscience Holdings (RGC) Valuation After Department Of Justice Investigation News
Simply Wall St. âĸ 2026-03-06T13:11:29Z
Don't Even Think About Buying Regencell Bioscience Stock Until You See This 1 Red Flag
Motley Fool âĸ 2026-03-05T22:20:00Z
Forget Regencell Bioscience: This Blue Chip Drug Maker Is the Boring Compounder You Need
Motley Fool âĸ 2026-03-01T17:23:00Z
These 3 Growth Stocks Wonât Be This Cheap Forever
24/7 Wall St. âĸ 2026-02-19T17:28:34Z
US Stock Market Today S&P 500 Futures Slip As Inflation And Bank Earnings Loom
Simply Wall St. âĸ 2026-01-14T10:09:47Z
US Stock Market Today S&P 500 Futures Edge Lower As Jobs And Inflation Collide
Simply Wall St. âĸ 2026-01-09T10:08:57Z
This Stock Soared 9,800% in 2025. Here's 1 Key Reason Why Investors Are Piling In (Spoiler: It's Regencell Bioscience Holdings (RGC) Stock)
Motley Fool âĸ 2025-11-24T14:05:00Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|
| Revenue | ||||
| Total Revenue | - | $0 | $0 | $0 |
| Operating Revenue | - | $0 | $0 | $0 |
| Expenses | ||||
| Total Expenses | - | $4,736,726 | $6,273,671 | $7,617,770 |
| Other Income Expense | - | $373,505 | $211,342 | $23,215 |
| Other Non Operating Income Expenses | - | $373,505 | $211,342 | $23,215 |
| Operating Expense | - | $4,736,726 | $6,273,671 | $7,617,770 |
| Selling And Marketing Expense | - | $125,427 | $262,664 | $25,275 |
| General And Administrative Expense | - | $3,545,066 | $4,429,379 | $5,080,341 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | - | $-4,301,837 | $-5,871,130 | $-7,445,943 |
| Normalized Income | - | $-4,301,837 | $-5,871,130 | $-7,445,943 |
| Net Income From Continuing And Discontinued Operation | - | $-4,301,837 | $-5,871,130 | $-7,445,943 |
| Total Operating Income As Reported | - | $-4,736,726 | $-6,273,671 | $-7,617,770 |
| Net Income Common Stockholders | - | $-4,301,837 | $-5,871,130 | $-7,445,943 |
| Net Income | - | $-4,301,837 | $-5,871,130 | $-7,445,943 |
| Net Income Including Noncontrolling Interests | - | $-4,363,221 | $-6,062,329 | $-7,594,555 |
| Net Income Continuous Operations | - | $-4,363,221 | $-6,062,329 | $-7,594,555 |
| Pretax Income | - | $-4,363,221 | $-6,062,329 | $-7,594,555 |
| Operating Income | - | $-4,736,726 | $-6,273,671 | $-7,617,770 |
| Per Share | ||||
| Diluted EPS | $-0.01 | $-0.01 | $-0.01 | $-0.02 |
| Basic EPS | $-0.01 | $-0.01 | $-0.01 | $-0.02 |
| Other | ||||
| Diluted Average Shares | $494,488,908 | $494,488,908 | $494,488,908 | $486,616,866 |
| Basic Average Shares | $494,488,908 | $494,488,908 | $494,488,908 | $486,616,866 |
| Tax Effect Of Unusual Items | - | $0 | $0 | $0 |
| Tax Rate For Calcs | - | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | - | $-3,991,138 | $-5,503,984 | $-7,013,373 |
| Reconciled Depreciation | - | $745,588 | $769,687 | $604,397 |
| EBITDA (Bullshit earnings) | - | $-3,991,138 | $-5,503,984 | $-7,013,373 |
| EBIT | - | $-4,736,726 | $-6,273,671 | $-7,617,770 |
| Diluted NI Availto Com Stockholders | - | $-4,301,837 | $-5,871,130 | $-7,445,943 |
| Minority Interests | - | $61,384 | $191,199 | $148,612 |
| Tax Provision | - | $0 | $0 | $0 |
| Research And Development | - | $1,066,233 | $1,581,628 | $2,512,154 |
| Selling General And Administration | - | $3,670,493 | $4,692,043 | $5,105,616 |
| Other Gand A | - | $3,545,066 | $4,429,379 | $5,080,341 |
| Salaries And Wages | - | - | $900,000 | $1,500,000 |
Fetched: 2026-06-20
Balance Sheet (Annual)
| Metric | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $8,218,699 | $12,030,333 | $17,065,498 | $-3,997,637 |
| Total Assets | $8,438,211 | $12,621,755 | $18,018,918 | $340,134 |
| Total Non Current Assets | $324,198 | $1,000,412 | $1,574,322 | $273,285 |
| Non Current Prepaid Assets | $97,684 | $108,499 | $114,302 | $19,106 |
| Current Assets | $8,114,013 | $11,621,343 | $16,444,596 | $66,849 |
| Receivables | $152,778 | $56,548 | $27,598 | $7,436 |
| Other Receivables | $152,778 | $56,548 | $27,598 | $7,436 |
| Cash Cash Equivalents And Short Term Investments | $7,961,235 | $11,564,795 | $16,416,998 | $59,413 |
| Cash And Cash Equivalents | $2,961,235 | $1,564,795 | $6,416,998 | $59,413 |
| Cash Financial | $2,961,235 | $1,564,795 | $6,416,998 | $59,413 |
| Non Current Deferred Assets | - | - | $0 | $172,314 |
| Prepaid Assets | - | - | $27,598 | $7,436 |
| Debt | ||||
| Total Debt | $85,741 | $463,669 | $771,255 | $3,681,969 |
| Long Term Debt And Capital Lease Obligation | $25,934 | $25,406 | $360,268 | $0 |
| Current Debt And Capital Lease Obligation | $59,807 | $438,263 | $410,987 | $3,681,969 |
| Net Debt | - | - | - | $3,622,556 |
| Current Debt | - | - | - | $3,681,969 |
| Other Current Borrowings | - | - | - | $3,681,969 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $219,512 | $632,320 | $938,032 | $4,337,771 |
| Total Non Current Liabilities Net Minority Interest | $25,934 | $25,406 | $360,268 | $0 |
| Current Liabilities | $193,578 | $606,914 | $577,764 | $4,337,771 |
| Payables And Accrued Expenses | $133,771 | $168,651 | $166,777 | $655,802 |
| Payables | $8,443 | $10,570 | $15,650 | $82,812 |
| Equity | ||||
| Common Stock Equity | $8,218,699 | $12,030,333 | $17,065,498 | $-3,997,637 |
| Total Equity Gross Minority Interest | $8,218,699 | $11,989,435 | $17,080,886 | $-3,997,637 |
| Stockholders Equity | $8,218,699 | $12,030,333 | $17,065,498 | $-3,997,637 |
| Gains Losses Not Affecting Retained Earnings | $-45,766 | $-86,658 | $0 | - |
| Other Equity Adjustments | $-45,766 | $-86,658 | - | - |
| Retained Earnings | $-21,616,903 | $-17,315,066 | $-11,443,936 | $-3,997,993 |
| Other | ||||
| Ordinary Shares Number | $494,488,908 | $494,488,908 | $494,488,908 | $480,399,990 |
| Share Issued | $494,488,908 | $494,488,908 | $494,488,908 | $480,399,990 |
| Tangible Book Value | $8,218,699 | $12,030,333 | $17,065,498 | $-3,997,637 |
| Invested Capital | $8,218,699 | $12,030,333 | $17,065,498 | $-315,668 |
| Working Capital | $7,920,435 | $11,014,429 | $15,866,832 | $-4,270,922 |
| Capital Lease Obligations | $85,741 | $463,669 | $771,255 | $0 |
| Total Capitalization | $8,218,699 | $12,030,333 | $17,065,498 | $-3,997,637 |
| Minority Interest | $0 | $-40,898 | $15,388 | $0 |
| Additional Paid In Capital | $29,881,238 | $29,431,927 | $28,509,304 | $256 |
| Capital Stock | $130 | $130 | $130 | $100 |
| Common Stock | $130 | $130 | $130 | $100 |
| Long Term Capital Lease Obligation | $25,934 | $25,406 | $360,268 | $0 |
| Current Capital Lease Obligation | $59,807 | $438,263 | $410,987 | $0 |
| Current Accrued Expenses | $125,328 | $158,081 | $151,127 | $572,990 |
| Dueto Related Parties Current | $8,443 | $10,570 | $15,650 | $82,812 |
| Net PPE | $226,514 | $891,913 | $1,460,020 | $81,865 |
| Accumulated Depreciation | $-784,165 | $-476,164 | $-186,119 | $-35,972 |
| Gross PPE | $1,010,679 | $1,368,077 | $1,646,139 | $117,837 |
| Leases | $623,804 | $621,417 | $601,527 | $117,837 |
| Other Properties | $84,780 | $451,084 | $747,426 | - |
| Machinery Furniture Equipment | $302,095 | $295,576 | $297,186 | $0 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $5,000,000 | $10,000,000 | $10,000,000 | $0 |
Fetched: 2026-06-20
Cash Flow Statement (Annual)
| Metric | 2024-06-30 | 2023-06-30 | 2022-06-30 | 2021-06-30 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-4,007,063 | $-4,990,341 | $-6,047,931 | $-767,311 |
| Operating Activities | ||||
| Operating Cash Flow | $-4,001,687 | $-4,962,949 | $-5,267,055 | $-767,311 |
| Cash Flow From Continuing Operating Activities | $-4,001,687 | $-4,962,949 | $-5,267,055 | $-767,311 |
| Operating Gains Losses | - | $1,415 | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-5,376 | $-27,392 | $-780,876 | - |
| Investing Cash Flow | $5,242,624 | $58,978 | $-10,780,876 | $0 |
| Cash Flow From Continuing Investing Activities | $5,242,624 | $58,978 | $-10,780,876 | $0 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $0 | $0 | $22,673,485 | $0 |
| Financing Cash Flow | $102,282 | $134,913 | $22,405,516 | $439,745 |
| Cash Flow From Continuing Financing Activities | $102,282 | $134,913 | $22,405,516 | $439,745 |
| Net Other Financing Charges | $102,282 | $134,913 | $164,000 | $-172,314 |
| Net Common Stock Issuance | $0 | $0 | $22,673,485 | $0 |
| Common Stock Issuance | $0 | $0 | $22,673,485 | $0 |
| Other | ||||
| Interest Paid Supplemental Data | $0 | $0 | $0 | $0 |
| Income Tax Paid Supplemental Data | $0 | $0 | $0 | $0 |
| End Cash Position | $2,961,235 | $1,564,795 | $6,416,998 | $59,413 |
| Beginning Cash Position | $1,564,795 | $6,416,998 | $59,413 | $386,979 |
| Effect Of Exchange Rate Changes | $53,221 | $-83,145 | $0 | $0 |
| Changes In Cash | $1,343,219 | $-4,769,058 | $6,357,585 | $-327,566 |
| Net Issuance Payments Of Debt | $0 | $0 | $-431,969 | $612,059 |
| Net Short Term Debt Issuance | $0 | $0 | $-431,969 | $612,059 |
| Net Investment Purchase And Sale | $5,248,000 | $85,400 | $-10,000,000 | $0 |
| Sale Of Investment | $10,248,000 | $10,085,400 | $0 | $0 |
| Purchase Of Investment | $-5,000,000 | $-10,000,000 | $-10,000,000 | $0 |
| Net PPE Purchase And Sale | $-5,376 | $-26,422 | $-780,876 | $0 |
| Sale Of PPE | $0 | $970 | $0 | $0 |
| Purchase Of PPE | $-5,376 | $-27,392 | $-780,876 | $0 |
| Change In Working Capital | $-585,365 | $-508,945 | $-1,024,071 | $552,978 |
| Change In Other Current Liabilities | $-465,070 | $-487,672 | $-430,421 | $0 |
| Change In Payables And Accrued Expense | $-34,880 | $1,874 | $-489,025 | $560,802 |
| Change In Accrued Expense | $-32,753 | $6,954 | $-421,863 | $477,990 |
| Change In Payable | $-2,127 | $-5,080 | $-67,162 | $82,812 |
| Change In Prepaid Assets | $-85,415 | $-23,147 | $-104,625 | $-7,824 |
| Other Non Cash Items | $-248,000 | $-85,400 | $-10,733 | - |
| Stock Based Compensation | $449,311 | $922,623 | $2,757,907 | $0 |
| Depreciation Amortization Depletion | $745,588 | $769,687 | $604,397 | $26,456 |
| Depreciation And Amortization | $745,588 | $769,687 | $604,397 | $26,456 |
| Depreciation | $745,588 | $769,687 | $604,397 | $26,456 |
| Gain Loss On Sale Of PPE | $0 | $1,415 | $0 | $0 |
| Net Income From Continuing Operations | $-4,363,221 | $-6,062,329 | $-7,594,555 | $-1,346,745 |
| Issuance Of Debt | - | - | - | $612,059 |
| Short Term Debt Issuance | - | - | - | $612,059 |
Fetched: 2026-06-20